Home › Funds › D. E. Shaw & Co › ZNTL
D. E. Shaw & Co position in ZNTL
ZENTALIS PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)546.57K sh
Reported value held$2.65M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 54.44K | $3.63M | New |
| Q4 2021 | 18.09K | $1.52M | Reduce |
| Q1 2022 | 20.96K | $967.00K | Add |
| Q2 2022 | 54.74K | $1.54M | Add |
| Q3 2022 | 29.11K | $631.00K | Reduce |
| Q3 2023 | 37.44K | $751.03K | New |
| Q1 2024 | 14.29K | $225.23K | New |
| Q2 2024 | 240.34K | $983.00K | Add |
| Q3 2024 | 1.13M | $4.15M | Add |
| Q4 2024 | 1.24M | $3.76M | Add |
| Q1 2025 | 1.12M | $1.78M | Reduce |
| Q2 2025 | 1.20M | $1.39M | Add |
| Q3 2025 | 1.41M | $2.13M | Add |
| Q4 2025 | 1.66M | $2.24M | Add |
| Q1 2026 | 1.48M | $3.47M | Reduce |
| Q2 2026 | 546.57K | $2.65M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ZNTL
- BlackRock Inc 3.75M sh · $18.20M · Q2 2026
- Two Sigma Investments 3.02M sh · $14.67M · Q2 2026
- Citadel Advisors 2.34M sh · $11.34M · Q2 2026
- Renaissance Technologies 1.61M sh · $7.80M · Q2 2026
- Geode Capital Management 1.28M sh · $6.23M · Q2 2026
- Bank of America Corp 1.11M sh · $5.41M · Q2 2026
- Vanguard Group 2.86M sh · $3.86M · Q4 2025
- Millennium Management 664.28K sh · $3.22M · Q2 2026
- Marshall Wace 591.47K sh · $2.87M · Q2 2026
- Morgan Stanley 471.25K sh · $2.29M · Q2 2026
- Northern Trust Corp 388.30K sh · $1.88M · Q2 2026